Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Advances in Neurology
|
January 1, 1982
Exacerbation detection in multiple sclerosis by clinical and evoked potential techniques: a preliminary report
W Likosky, R S Elmore
The Western Journal of Medicine
|
June 1, 1989
Screening for sleep apnea
J J Nestor, W Likosky, G Sinclair
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine
|
June 8, 2001
Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject
D C Mohr, A C Boudewyn, W Likosky, et al.
Journal of Behavioral Medicine
|
August 1, 1997
Identification of Beck Depression Inventory items related to multiple sclerosis
D C Mohr, D E Goodkin, W Likosky, et al.
Archives of Neurology
|
May 1, 1997
Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis
D C Mohr, D E Goodkin, W Likosky, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 1, 1996
Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment
D C Mohr, D E Goodkin, W Likosky, et al.
Archives of Neurology
|
October 16, 1999
Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis
D C Mohr, W Likosky, P Dwyer, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association
|
August 4, 1999
The psychosocial impact of multiple sclerosis: exploring the patient's perspective
D C Mohr, L P Dick, D Russo, et al.
Journal of Consulting and Clinical Psychology
|
April 26, 2000
Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis
D C Mohr, W Likosky, A Bertagnolli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 13, 1999
Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a
D C Mohr, W Likosky, A C Boudewyn, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Advances in Neurology
|
January 1, 1982
Exacerbation detection in multiple sclerosis by clinical and evoked potential techniques: a preliminary report
W Likosky, R S Elmore
The Western Journal of Medicine
|
June 1, 1989
Screening for sleep apnea
J J Nestor, W Likosky, G Sinclair
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine
|
June 8, 2001
Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject
D C Mohr, A C Boudewyn, W Likosky, et al.
Journal of Behavioral Medicine
|
August 1, 1997
Identification of Beck Depression Inventory items related to multiple sclerosis
D C Mohr, D E Goodkin, W Likosky, et al.
Archives of Neurology
|
May 1, 1997
Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis
D C Mohr, D E Goodkin, W Likosky, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 1, 1996
Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment
D C Mohr, D E Goodkin, W Likosky, et al.
Archives of Neurology
|
October 16, 1999
Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis
D C Mohr, W Likosky, P Dwyer, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association
|
August 4, 1999
The psychosocial impact of multiple sclerosis: exploring the patient's perspective
D C Mohr, L P Dick, D Russo, et al.
Journal of Consulting and Clinical Psychology
|
April 26, 2000
Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis
D C Mohr, W Likosky, A Bertagnolli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 13, 1999
Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a
D C Mohr, W Likosky, A C Boudewyn, et al.
Page
of 1